Search - tctmd.com

Displaying 81 - 100 of 422

Sort: Relevancy | Date

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Daily News

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

L.A. McKeown

June 11, 2024

Presentation NY Valves 2024

Myosin Inhibitors and Novel Medical Therapies for HCM

Presenter: Mark V. Sherrid

June 07, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News ESC Heart Failure 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

News Conference News ESC Heart Failure 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Michael O'Riordan

May 13, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

Wearable-Tracked Walking Behavior Hints at Subclinical HF

Caitlin E. Cox

April 23, 2024

News Daily News

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Yael L. Maxwell

April 18, 2024

News Daily News

New Heart Failure After AF Diagnosis Merits More Attention

Todd Neale

April 18, 2024

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

News Conference News EHRA 2024

Ultralow-Temperature Cryoablation Promising for Monomorphic VT

Todd Neale

April 12, 2024

Advertisement

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Semaglutide Has Similar Benefits in Women and Men With HFpEF

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

Myosin Inhibitors and Novel Medical Therapies for HCM

June 2024 Dispatch for the CV Team

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

May 2024 Dispatch for the CV Team

Wearable-Tracked Walking Behavior Hints at Subclinical HF

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

New Heart Failure After AF Diagnosis Merits More Attention

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Ultralow-Temperature Cryoablation Promising for Monomorphic VT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content